Showing 1 - 10 of 7,592
law — or antitrust law, as it is known in the United States — with intellectual property (IP). It examines whether and how … IP rights alter the substantive scope of antitrust law, either by operation of statute or as a matter of economic policy …. It discusses a wide variety of antitrust claims, alleging collusion, exclusion, or both, that have been raised against IP …
Persistent link: https://www.econbiz.de/10012934047
battlefield : standard essential patents / I. Forrester & M. Domecq -- Antitrust and intellectual property in the United States … FRAND royalties / G. Ghidini & G. Trabucco -- Unified Patent Court & antitrust / G. Muscolo -- Online platforms and …, innovation and competition : is there any scope for aftermarkets? / A. Pezzoli & C. D'Amore -- Rethinking monopolies / C. Birss …
Persistent link: https://www.econbiz.de/10012216553
Persistent link: https://www.econbiz.de/10011872261
Persistent link: https://www.econbiz.de/10012054695
Persistent link: https://www.econbiz.de/10012054656
Persistent link: https://www.econbiz.de/10003323109
The objective of granting patent rights is to confer monopoly rights, the rights to exclusive use and exploitation of … similarity or identity in the claims as made by the applicant may be challenged before the patent office in an infringement suit …-infringement shifts upon the defendant. Moreover, in India, there is no presumption against the validity of the grant of patent by mere …
Persistent link: https://www.econbiz.de/10014354486
Nowadays, merger control predominantly relies upon a strict analysis of the effects from merger and acquisitions on effective competition. However, there is scope for so-called public interest considerations in several European merger control regimes and recently a number of European politicians...
Persistent link: https://www.econbiz.de/10012057286
essential to accelerate pharmaceutical innovation. Patents threaten the potential of partnership strategies, however, by making …Public-private partnerships offer a promising alternative paradigm for pharmaceutical innovation in complex disease … without patents. This Article suggests that the current “pre-competitive” approach to partnership strategies in pharmaceutical …
Persistent link: https://www.econbiz.de/10014136820